Related references
Note: Only part of the references are listed.Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects
Jeffrey A. Cohen et al.
LANCET NEUROLOGY (2012)
Challenges to clinical trials in multiple sclerosis: outcome measures in the era of disease-modifying drugs
Megan Hyland et al.
CURRENT OPINION IN NEUROLOGY (2011)
Predicting employment status in multiple sclerosis patients: the utility of the MS functional composite
Kimia Honarmand et al.
JOURNAL OF NEUROLOGY (2011)
Improving power to detect disease progression in multiple sclerosis through alternative analysis strategies
Brian Healy et al.
JOURNAL OF NEUROLOGY (2011)
Disability status and quality of life in multiple sclerosis: non-linearity of the Expanded Disability Status Scale (EDSS)
Sabine Twork et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2010)
Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test
A. S. Drake et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
L. V. A. E. Bosma et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
The search for responsive clinical endpoints in primary progressive multiple sclerosis
L. V. A. E. Bosma et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Assessing disability progression with the Multiple Sclerosis Functional Composite
R. A. Rudick et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Evaluation of response of multiple sclerosis (MS) relapse to oral high-dose methylprednisolone: usefulness of MS functional composite and Expanded Disability Status Scale
A. M. Pascual et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study
B. Brochet et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Self-rated physical health predicts change in disability in multiple sclerosis
J. Drulovic et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Disability as an outcome in MS clinical trials
G. C. Ebers et al.
NEUROLOGY (2008)
Alemtuzumab vs. Interferon beta-1a in early multiple sclerosis
Alasdair J. Coles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The reliability of the MSFC and its components
E. Rosti-Otajarvi et al.
ACTA NEUROLOGICA SCANDINAVICA (2008)
Clinical outcome measures in multiple sclerosis
Maria Pia Amato et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Optimal reference population for the multiple sclerosis functional composite
R. J. Fox et al.
MULTIPLE SCLEROSIS (2007)
How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
J. J. Kragt et al.
MULTIPLE SCLEROSIS (2006)
Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis
J. J. Kragt et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: results from the IMPACT study
DM Miller et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Quality of life in multiple sclerosis: Does information-processing speed have an independent effect?
SL Barker-Collo
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2006)
Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies
S Ozakbas et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Paced visual serial addition test in multiple sclerosis
G Nagels et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2005)
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis
ML Baier et al.
NEUROLOGY (2005)
The multiple sclerosis functional composite: different practice effects in the three test components
A Solari et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale
M Ravnborg et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
The Paced Auditory Serial Addition Test: to what extent is it performed as instructed, and is it associated with disease course?
H Coo et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
A comparison of health utility measures for the evaluation of multiple sclerosis treatments
JD Fisk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis
S Ozakbas et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite
ELJ Hoogervorst et al.
MULTIPLE SCLEROSIS (2004)
SaGAS, the Short and Graphic Ability Score: an alternative scoring method for the motor components of the Multiple Sclerosis Functional Composite
C Vaney et al.
MULTIPLE SCLEROSIS (2004)
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite
LJ Balcer et al.
NEUROLOGY (2003)
Multiple sclerosis functional composite:: impact of reference population and interpretation of changes
BMJ Uitdehaag et al.
MULTIPLE SCLEROSIS (2002)
The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis
RA Rudick et al.
MULTIPLE SCLEROSIS (2002)
An expert system for the evaluation of EDSS in multiple sclerosis
M Gaspari et al.
ARTIFICIAL INTELLIGENCE IN MEDICINE (2002)
Quantitative functional measures in MS: What is a reliable change?
SR Schwid et al.
NEUROLOGY (2002)
Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis
T Patzold et al.
ACTA NEUROLOGICA SCANDINAVICA (2002)
A study validating changes in the Multiple Sclerosis Functional Composite
ELJ Hoogervorst et al.
ARCHIVES OF NEUROLOGY (2002)
Clinical outcome measures for research in multiple sclerosis
LJ Balcer
JOURNAL OF NEURO-OPHTHALMOLOGY (2001)
Use of the Multiple Sclerosis Functional Composite as an outcome measure in a phase 3 clinical trial
JA Cohen et al.
ARCHIVES OF NEUROLOGY (2001)
Concurrent validity of the MS functional composite using MRI as a biological disease marker
NF Kalkers et al.
NEUROLOGY (2001)
Are quantitative functional measures more sensitive to worsening MS than traditional measures?
SR Schwid et al.
NEUROLOGY (2000)
Kurtzke scales revisited: the application of psychometric methods to clinical intuition
J Hobart et al.
BRAIN (2000)
Intrarater and interrater reliability of the MS functional composite outcome measure
JA Cohen et al.
NEUROLOGY (2000)
MS Functional Composite -: Relation to disease phenotype and disability strata
NF Kalkers et al.
NEUROLOGY (2000)
Share Paper
